Agucare app analytics for November 30

Agucare

Agucare

  • developer@agucare.com
  • Google Play Store
  • Free
  • Medical
It is a safe, user-friendly telemedicine platform that creates a direct channel between the health professional and the patient, with all the necessary functionalities to be able to carry out a correct consultation and follow-up of the patient's treatment. It is an indispensable tool in the new form of doctor-patient relationship. Among the main functionalities considered are: video calls for teleconsultation, direct chat between doctor-patient that maintains the privacy and confidentiality of face-to-face care; generation of medical orders for procedures / exams and prescriptions, record of care per patient, personalized system of notifications of continuity of treatment.
Agucare

Agucare Usage Rank

The usage rank is based on Similarweb's algorithm that calculates current installs and active users over a 28-day period.

All Categories in
United States--
Medical in
United States--

Daily active users

Analyze usage patterns of Agucare users by viewing Agucare downloads and daily active users over time.

Users

Analyze usage patterns of Agucare users by viewing Agucare downloads and daily active users over time.

Unlock daily active users
SepOctNov

Agucare Ranking Stats Over Time

Similarweb's Usage Rank & Google Play Store Rank for Agucare

Rank

No Data Available

Agucare Ranking by Country

Counties in which Agucare has the highest ranking in its main categories


Users Interests & Top Categories

Top categories and apps used by Agucare users

No Data to Display

Top Competitors & Alternative Apps

Apps with a high probability of being used by the same users, from the same store.

Myrekod (Own Your Health)

Myrekod (Own Your Health)

Afya Rekod

Orthopedic Surgery Indications

Orthopedic Surgery Indications

Orthofixar - Medical Applications & Tools

Swanton's Cardiology Guide

Swanton's Cardiology Guide

Skyscape Medpresso Inc

MCSAID

MCSAID

Cardiology Apps

Agucare VS.

November 30, 2024